Skip to main content

Table 3 Mean percent change in lipid profile after 12 weeks in each treatment group

From: Synergistic combinatorial antihyperlipidemic study of selected natural antioxidants; modulatory effects on lipid profile and endogenous antioxidants

Parameters (%)

GROUP

TC value (95 % CI)

LDL-C value (95 % CI)

HDL-C value (95 % CI)

TG value (95 % CI)

VLDL-C (95 % CI)

LDL/HDL (95 % CI)

Atherogenic index (95 % CI)

1

Atorvastatin

−34.0 (−36.43, −31.57)

−36.42 (−39.00, −33.80)

34.20 (29.78, 38.62)

−30.80 (−32.74, −28.86)

−30.80 (−33.58, −28.02)

−52.66 (−62.56, −42.76)

−26.28 (−31.97, −20.59)

2

Proanthocyanidins (OPC)

−22.50 (−24.19, −20.81)

−23.68 (−25.50, −21.86)

19.44 (16.30, 22.58)

−25.07 (−27.33, −22.81)

−25.05 (−26.18, −23.92)

−36.09 (−40.21, −31.97)

−18.52 (−20.26, −16.78)

3

Nicotinic acid (NA)

−14.90 (−15.69, −14.11)

−15.75 (−16.87, −14.63)

26.8 (23.19, 30.41)

−19.88 (−21.48, −18.28)

−19.85 (−21.78, −17.92)

−33.57 (−37.57, −29.57)

−18.25 (−21.03, −15.47)

4

Pterostilbene (PT)

−26.22 (−27.59, −24.85)

−28.47 (−30.51, −26.43)

13.69 (10.32, 17.06)

−14.7 (−15.16, −14.24)

−14.71 (−16.48, −12.94)

−37.08 (−41.58, −32.58)

−11.4 (−13.12, −9.679)

5

OPC : NA 30:70

−23.36 (−24.68, −22.04)

−25.18 (−26.67, −23.69)

36.0 (31.41, 40.59)

−25.07 (−26.62, −23.52)

−25.05 (−27.19, −22.91)

−45.02 (−49.82, −40.22)

−23.63 (−26.88, −20.38)

6

OPC : NA 50:50

−25.58 (−26.81, −24.35)

−27.66 (−29.11, −26.21)

27.27 (24.54, 30.00)

−21.32 (−23.07, −19.57)

−21.31 (−22.97, −19.65)

−43.2 (−48.02, −38.38)

−19.07 (−21.10, −17.04)

7

OPC : NA 70:30

−32.13 (−33.84, −30.42)

−34.57 (−37.89, −31.25)

29.9 (25.39, 34.41)

−27.4 (−29.81, −24.99)

−27.4 (−29.48, −25.32)

−49.64 (−57.83, −41.45)

−23.08 (−25.94, −20.22)

8

OPC : PT 30:70

−36.79 (−39.00, −34.58)

−40.17 (−42.27, −38.07)

20.09 (17.50, 22.68)

−18.16 (−18.79, −17.53)

−18.13 (−19.63, −16.63)

−50.2 (−53.74, −46.66)

−15.24 (−17.65, −12.83)

9

OPC : PT 50:50

−32.13 (−34.13, −30.13)

−34.97 (−37.36, −32.58)

27.27 (22.98, 31.56)

−21.33 (−23.07, −19.59)

−21.31 (−22.97, −19.65)

−48.9 (−54.96, −42.84)

−19.07 (−21.11, −17.03)

10

OPC : PT 70:30

−35.73 (−38.01, −33.45)

−38.97 (−41.34, −36.60)

27.45 (23.16, 31.74)

−27.38 (−29.88, −24.88)

−27.39 (−29.47, −25.31)

−49.64 (−57.82, −41.46)

−22.35 (−25.11, −19.59)

11

NA : PT 30:70

−34.99 (−37.18, −32.80)

−38.0 (−39.77, −36.23)

20.05 (17.56, 17.56)

−20.17 (−22.24, −18.10)

−20.16 (−21.41, −18.91)

−48.36 (−52.55, −44.17)

−16.15 (−17.81, −14.49)

12

NA : PT 50:50

−31.71 (−33.47, −29.95)

−34.57 (−36.54, −32.60)

31.62 (28.20, 35.04)

−22.19 (−23.68, −20.70)

−22.19 (−24.20, −20.18)

−50.30 (−57.47, −43.13)

−20.8 (−23.07, −18.53)

13

NA : PT 70:30

−30.34 (−29.62, −26.82)

−33.13 (−32.21, −29.33)

34.53 (29.17, 39.89)

−22.2 (−23.45, −20.95)

−22.2 (−23.99, −20.41)

−50.30 (−55.64, −41.48)

−21.72 (−25.18, −18.26)

14

OPC : NA : PT 50:30:20

−40.49 (−42.95, −38.03)

−44.1 (−46.86, −41.34)

37.26 (32.61, 41.91)

−27.09 (−28.92, −25.26)

−27.08 (−28.92, −25.24)

−59.30 (−68.18, −50.42)

−25.09 (−28.30, −21.88)

15

OPC : NA : PT 50:20:30

−39.53 (−41.86, −37.20)

−43.13 (−45.10, −41.28)

32.5 (29.48, 35.52)

−25.36 (−27.52, −23.20)

−23.59 (−26.15, −21.03)

−57.84 (−66.56, −49.12)

−23.45 (−25.85, −21.05)

16

OPC : NA : PT 20:50:30

−37.80 (−39.74, −35.86)

−41.4 (−44.20, −38.60)

38.99 (32.84, 45.14)

−25.07 (−25.76, −24.38)

−25.05 (−26.59, −23.51)

−57.80 (−68.45, −47.15)

−24.50 (−26.67, −22.33)

  1. Data is presented as mean percent change from the disease control at 95 % confidence interval